RELMADA THERAPEUTICS, INC. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
RELMADA THERAPEUTICS, INC. (RLMD) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals of $1.61 million as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals · last filed 2026-03-19
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $1.61M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $1.40M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $1.62M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $1.55M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals as first filed |
|---|---|---|
| 2025-12-31 | $1.61M 10-K · filed 2026-03-19 | |
| 2024-12-31 | $1.40M 10-K · filed 2026-03-19 | |
| 2023-12-31 | $1.62M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $1.55M 10-K · filed 2024-03-19 | |
| 2021-12-31 | $655.00K 10-K · filed 2023-03-23 | |
| 2020-12-31 | $645.00K 10-K · filed 2022-03-25 | |
| 2019-12-31 | $133.00K 10-K · filed 2021-03-24 | |
| 2019-06-30 | $206.00K 10-K · filed 2021-03-24 | |
| 2018-06-30 | $13.00K 10-KT · filed 2020-03-26 | |
| 2017-06-30 | $23.00K 10-K · filed 2018-09-28 | |
| 2016-06-30 | $67.00K 10-K · filed 2017-09-28 | |
| 2015-06-30 | $46.00K 10-K · filed 2016-09-09 | $46.40K 10-K · filed 2015-09-11 |
| 2014-06-30 | $22.90K 10-K · filed 2015-09-11 | |
| 2013-12-31 | $44.70K 10-KT · filed 2014-09-09 | |
| 2012-12-31 | $4.00K 8-K · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |